Data / Drug companies / Valacyclovir
Valacyclovir: 27 companies and 60 products in the FDA NDC directory
Valacyclovir is listed in the FDA National Drug Code Directory by 27 companies, with 60 products in commercial distribution. 60 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, and the newest product started marketing on August 12, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 27
- Products
- 60
- Generic (ANDA) products
- 60 (100.0%)
- Application numbers
- 5
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list valacyclovir
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 6 | tablet; tablet, film coated | Generic drugs (ANDA) | February 14, 2023 |
| NuCare Pharmaceuticals,Inc. | 6 | tablet, film coated; tablet | Generic drugs (ANDA) | February 14, 2023 |
| Remedyrepack Inc. | 4 | tablet, film coated; tablet | Generic drugs (ANDA) | May 14, 2026 |
| Bryant Ranch Prepack | 3 | tablet; tablet, film coated | Generic drugs (ANDA) | February 14, 2023 |
| Proficient Rx LP | 3 | tablet; tablet, film coated | Generic drugs (ANDA) | February 14, 2023 |
| Asclemed USA Inc. | 2 | tablet | Generic drugs (ANDA) | February 14, 2023 |
| Camber Pharmaceuticals, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | May 25, 2015 |
| Chartwell RX, LLC | 2 | tablet | Generic drugs (ANDA) | October 1, 2018 |
| Coupler LLC | 2 | tablet, film coated | Generic drugs (ANDA) | May 4, 2026 |
| Direct_Rx | 2 | tablet | Generic drugs (ANDA) | June 26, 2025 |
| Golden State Medical Supply, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | January 31, 2007 |
| Mylan Pharmaceuticals Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | May 24, 2010 |
| Northwind Health Company, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | April 21, 2026 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet, film coated; tablet | Generic drugs (ANDA) | February 14, 2023 |
| Preferred Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | April 21, 2026 |
| Quallent Pharmaceuticals Health LLC | 2 | tablet, film coated | Generic drugs (ANDA) | October 14, 2022 |
| Redpharm Drug | 2 | tablet, film coated; tablet | Generic drugs (ANDA) | February 14, 2023 |
| Sportpharm LLC | 2 | tablet | Generic drugs (ANDA) | February 14, 2023 |
| St. Mary's Medical Park Pharmacy | 2 | tablet, film coated; tablet | Generic drugs (ANDA) | August 12, 2026 |
| Sun Pharmaceutical Industries, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | December 19, 2020 |
| Westminster Pharmaceuticals, LLC | 2 | tablet | Generic drugs (ANDA) | February 14, 2023 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | January 31, 2007 |
| Direct RX | 1 | tablet, film coated | Generic drugs (ANDA) | January 1, 2015 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | May 25, 2015 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | May 25, 2015 |
| Safecor Health, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | April 3, 2026 |
| Yiling Pharmaceutical, Inc. | 1 | tablet | Generic drugs (ANDA) | October 1, 2018 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 33 | 55% |
| Tablet | 27 | 45% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 60 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor | 60 |
| Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor | 60 |
| Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor | 60 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.